Why GRAL? GRAIL, Inc. Analysis, Price & AI Insights | Whystock
GRAL
$54.40-1.26 (-2.26%)
Pre-Market$54.47+0.07 (+0.14%)· Last close May 5
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.